Assenagon Asset Management S.A. Raises Stake in Inspire Medical Systems, Inc. $INSP

Assenagon Asset Management S.A. raised its holdings in Inspire Medical Systems, Inc. (NYSE:INSP) by 96.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 520,174 shares of the company’s stock after purchasing an additional 255,175 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Inspire Medical Systems were worth $26,831,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in INSP. CWM LLC grew its holdings in shares of Inspire Medical Systems by 216.1% during the fourth quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after buying an additional 242 shares during the last quarter. Havemeyer Place LP acquired a new stake in Inspire Medical Systems during the 4th quarter worth approximately $39,000. V Square Quantitative Management LLC purchased a new position in shares of Inspire Medical Systems in the 4th quarter valued at approximately $40,000. Smartleaf Asset Management LLC increased its holdings in shares of Inspire Medical Systems by 84.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after purchasing an additional 205 shares during the period. Finally, Larson Financial Group LLC increased its holdings in shares of Inspire Medical Systems by 21,266.7% in the third quarter. Larson Financial Group LLC now owns 641 shares of the company’s stock valued at $48,000 after purchasing an additional 638 shares during the period. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Stock Performance

NYSE:INSP opened at $45.65 on Friday. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 10.17, a price-to-earnings-growth ratio of 4.40 and a beta of 0.73. Inspire Medical Systems, Inc. has a one year low of $38.91 and a one year high of $147.03. The business’s 50-day simple moving average is $45.52 and its 200 day simple moving average is $65.66.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.38. The business had revenue of $204.58 million for the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, equities research analysts predict that Inspire Medical Systems, Inc. will post 0.93 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Piper Sandler cut Inspire Medical Systems from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $85.00 to $55.00 in a research report on Tuesday, May 5th. Robert W. Baird dropped their price objective on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Weiss Ratings downgraded Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 6th. Oppenheimer reissued a “market perform” rating on shares of Inspire Medical Systems in a research note on Monday, June 15th. Finally, Zacks Research lowered shares of Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $81.05.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.